BBNX: SEC Form FWP filed by Beta Bionics Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for BBNX
Across the 21 sessions after earlier BBNX headlines, the stock closed higher 11 times and lower 10 times, with a median move of 3.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | BBNX | SPY |
|---|---|---|---|
| Sep 16, 2026 | Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock | +15.3% | -0.4% |
| Sep 14, 2026 | Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm | +1.0% | -0.4% |
| Aug 21, 2026 | William Blair initiated coverage on Beta Bionics | -2.2% | +0.4% |
| Jul 30, 2026 | Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | -5.9% | +1.7% |
| Jul 28, 2026 | UBS resumed coverage on Beta Bionics with a new price target | -1.2% | +0.2% |
| Jul 1, 2026 | Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026 | +6.6% | -0.1% |
Quantisnow market dataNASDAQ
BBNX
Beta Bionics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2025
Get push alerts for BBNX
Full BBNX profile on Quantisnow Follow BBNX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time